Back
Regeneron Pharmaceuticals Stock Predictions

ALERT: Q3 Could Be a Pivotal Quarter for Nasdaq Stocks
Click Here to Download Your FREE Stock Report Now
Sell
44
REGN
Regeneron Pharmaceuticals
Last Price:
$547.36
Seasonality Move:
8.46%
7 Day Trial
ALL ACCESS PASS
$
7

Slow Market? Try This Instead
See how it works now.Regeneron Pharmaceuticals Stock Forecast
-
Over the next 52 weeks, Regeneron Pharmaceuticals has on average historically risen by 28.7% based on the past 34 years of stock performance.
-
Regeneron Pharmaceuticals has risen higher in 21 of those 34 years over the subsequent 52-week period, corresponding to a historical accuracy of 61.76%
-
Is Regeneron Pharmaceuticals Stock Undervalued?The current Regeneron Pharmaceuticals [REGN] share price is $547.36. The Score for REGN is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
REGN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Regeneron Pharmaceuticals Stock Go Up Next Year?
-
Over the next 52 weeks, Regeneron Pharmaceuticals has on average historically risen by 28.7% based on the past 34 years of stock performance.
Regeneron Pharmaceuticals Stock Rating
Sell
44
Regeneron Pharmaceuticals (REGN)
is a Sell
Is Regeneron Pharmaceuticals overpriced?
-
Regeneron Pharmaceuticals has risen higher in 21 of those 34 years over the subsequent 52-week period, corresponding to a historical accuracy of 61.76%
Regeneron Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
S&P500
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
regeneron.com
52-Week Data
52-Week High:
1,211.20
52-Week Low:
476.49
Prediction Charts
Market Cap:
59.1B
Price in USD:
547.36
Volume:
456.4K
Beta:
0.94
Technical Analysis
SMA50:
552.25
SMA100:
600.16
SMA200:
721.27
52-Wk Change:
-46.55%
Stock Predictions
-
Is Regeneron Pharmaceuticals stock public?Yes, Regeneron Pharmaceuticals is a publicly traded company.
-
What is the Regeneron Pharmaceuticals stock quote today?The Regeneron Pharmaceuticals stock price is 547.36 USD today.
-
How to buy Regeneron Pharmaceuticals stock online?You can buy Regeneron Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Jun-13 | 518.25 | 529.24 | 529.55 | 514.98 |
Jun-16 | 532.88 | 522.68 | 538.20 | 520.22 |
Jun-17 | 519.27 | 508.86 | 523.01 | 508.70 |
Jun-18 | 508.51 | 513.58 | 519.17 | 503.25 |
Jun-20 | 521.05 | 509.72 | 521.31 | 506.38 |
Jun-23 | 510.00 | 511.92 | 516.18 | 507.61 |
Jun-24 | 515.79 | 522.27 | 527.45 | 515.79 |
Jun-25 | 521.40 | 520.29 | 525.63 | 516.99 |
Jun-26 | 520.00 | 521.00 | 524.52 | 514.79 |
Jun-27 | 521.79 | 521.00 | 531.21 | 517.39 |
Jun-30 | 520.21 | 525.00 | 526.08 | 518.90 |
Jul-1 | 523.97 | 534.91 | 548.04 | 521.00 |
Jul-2 | 533.66 | 547.74 | 551.50 | 529.69 |
Jul-3 | 547.75 | 547.36 | 555.00 | 546.61 |
Regeneron Pharmaceuticals Earnings
Regeneron Pharmaceuticals Earnings Report: Per Share Regeneron Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Regeneron Pharmaceuticals Forecast Revenue Growth
Regeneron Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Regeneron Pharmaceuticals and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $2.15 per share, an increase next quarter of $0.68 per share, a decrease this year of $9.47 per share, and an increase next year of $4.28 per share.
* Regeneron Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.